Accelerated Drug Development is Aim of Two Collaborations

Illumina and Pfizer are each heading up collaborations starring pharmaceutical heavy hitters who will work together to accelerate drug development, although in different ways.

Illumina and Vanderbilt University Medical Center’s Nashville Biosciences head up the Alliance for Genomic Discovery (AGD) with its team of founding biopharma members — AbbVie, Amgen, AstraZeneca, Bayer and Merck — will co-fund the whole-genome sequencing of 250,000 samples.

Pfizer and investment firm Flagship Pioneering say they aim to create a new pipeline of innovative medicines focused on addressing unmet needs in broad patient populations and diseases with high potential to benefit from a diverse range of technology platforms.

To read the full story, click here to subscribe.

Related Topics